HOME
LOGIN
THE MEDICAL LETTER
Subscribe
Current Issue
Previous Issues
Reference Tables
ABOUT US
The Medical Letter, Inc.
CONTINUING EDUCATION
Exams
DRUG INTERACTIONS
CONTACT US
The Medical Letter Mobile Home Page
CURRENT
ISSUE
1568
A lidocaine 1.8% patch (ZTlido – Scilex) has been approved by the FDA for treatment of pain associated with postherpetic neuralgia (PHN). A lidocaine 5% patch (Lidoderm, and generics) was approved earlier for the same indication and has been used off-label for treatment of other types of localized pain. Both of these patches are available only by prescription. Lidocaine 4% patches (Aspercreme, IcyHot, and others) are available over the counter for back, neck, shoulder, and joint...  read more...
More from issue 1568
Coming Soon
Drugs for Heart Failure
Esketamine Nasal Spray (Spravato) for Treatment-Resistant Depression
PrabotulinumtoxinA (Jeuveau) for Frown Lines
OTC Drugs for Seasonal Allergies
Ozenoxacin Cream (Xepi) for Impetigo
Recommend to Your Library  

We're Essential.   Begin your free trial  
Previous Issues
© 2019 The Medical Letter, Inc.